Radiological Investigation III: Pulmonary Angiogram and PET Scan
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Issues And Trends In Healthcare Delivery System
Radiological Investigation I: X-ray and CT
Imaging Studies I: CT and MRI
Ultrasonography
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 5, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
Adrian P Brady1, Bibb Allen2,3, Jaron Chong4
1University College Cork, Cork, Ireland.
This multi-society statement provides a framework for radiologists and healthcare institutions to evaluate, adopt, and oversee artificial intelligence software. It outlines key ethical and practical challenges to ensure these technologies remain safe and effective for patient care.
Area of Science:
Background:
No consensus exists regarding the standardized adoption of automated diagnostic software in medical imaging environments. That uncertainty drove international professional organizations to address the rapid proliferation of these digital solutions. Prior research has shown that while these technologies offer diagnostic advancements, they also introduce significant risks to patient safety. This gap motivated a collaborative effort to define best practices for clinical integration. It was already known that unregulated software deployment could lead to adverse outcomes in healthcare settings. That reality necessitated a comprehensive review of current procurement and oversight standards. No prior work had resolved the complexities of balancing innovation with rigorous clinical validation. This document synthesizes expert perspectives to guide stakeholders through the lifecycle of these emerging technologies.
Purpose Of The Study:
The aim of this statement is to define the practical problems and ethical issues surrounding the incorporation of digital diagnostic tools into medical practice. This document addresses the urgent need for standardized guidance as these technologies become increasingly available. The authors seek to provide a comprehensive summary for developers, regulators, and purchasers involved in the acquisition process. They intend to clarify the responsibilities of each party before these systems are introduced into clinical workflows. The motivation for this work stems from the potential for both beneficial and harmful impacts on patient care. By delineating main points of concern, the researchers hope to facilitate safer technology adoption across international healthcare systems. They also propose methods for assessing the stability and safety of these tools throughout their operational life. This effort serves as a foundational resource for stakeholders navigating the complexities of modern medical imaging innovation.
Main Methods:
The review approach involved a collaborative synthesis of expert opinions from five major international professional organizations. These groups examined existing literature to identify common challenges in the procurement and deployment of digital diagnostic systems. The authors analyzed regulatory requirements across different jurisdictions to provide a global perspective on software safety. They utilized a consensus-based framework to categorize practical problems encountered during the integration process. The team evaluated ethical considerations related to patient privacy and algorithmic bias in medical settings. They developed recommendations for monitoring system stability after initial implementation in clinical environments. This process included assessing the suitability of various tools for autonomous diagnostic tasks. The final document represents a unified position statement intended to guide healthcare institutions and developers.
Main Results:
Key findings from the literature indicate that these digital tools possess the capacity to transform healthcare through improved diagnostic accuracy and management. The authors report that the rapid expansion of these products necessitates a critical evaluation of all vendor claims. They identify that both positive and negative consequences arise from the current lack of standardized oversight. The statement highlights that developers must address specific technical concerns before introducing products into clinical practice. The researchers note that purchasers should conduct thorough assessments of software safety and utility prior to acquisition. They demonstrate that ongoing monitoring is required to ensure that systems remain stable during extended use. The analysis suggests that autonomous functions require careful governance to mitigate potential risks to patient outcomes. The findings confirm that a structured approach to implementation supports the safe adoption of these technologies.
Conclusions:
The authors propose that rigorous evaluation remains necessary before integrating new software into routine clinical workflows. They suggest that continuous monitoring of system performance helps identify potential degradation over time. Stakeholders should prioritize transparency regarding the training data used for model development. The researchers emphasize that autonomous functions require strict oversight to prevent diagnostic errors. They argue that collaborative efforts between developers and clinicians improve the reliability of these digital resources. The statement highlights that ethical considerations must guide the selection of products for hospital use. The authors conclude that standardized frameworks support safer implementation across diverse medical settings. They suggest that ongoing assessment ensures these tools continue to provide value to patient care.
The authors propose that stakeholders implement continuous performance monitoring and rigorous validation protocols. These measures help differentiate safe, effective products from those that might be unhelpful or potentially harmful to patients during routine diagnostic procedures.
The statement identifies ethical issues and practical problems as primary concerns. These include the need for transparency in product development and the requirement for clear guidelines regarding the potential for autonomous function in clinical environments.
The researchers argue that clinical validation is necessary to ensure software reliability. This process helps verify that the tools perform accurately across different patient populations and imaging hardware configurations before they are used for patient management.
The authors emphasize that training data quality plays a vital role in determining model performance. They suggest that purchasers should evaluate the diversity and representativeness of these datasets to ensure the software functions correctly in their specific hospital environment.
The researchers describe the phenomenon of model drift, where software performance degrades after deployment. They suggest that periodic audits are required to maintain the stability and safety of these tools throughout their operational lifespan.
The authors propose that international collaboration among professional societies establishes a unified standard for adoption. They claim this approach helps stakeholders navigate the complexities of integrating these innovations while maintaining high levels of patient safety.